Reimbursement Briefs: PCORI Projects; Joint Commission On Alarms

PCORI approves 82 new funding awards. The Joint Commission releases “R3 Report.” More reimbursement news in brief.

The Patient-Centered Outcomes Research Institute on Dec. 17 approved 82 new funding awards totaling $191 million. Of that amount, $97.3 million will support 53 comparative effectiveness research projects in 23 states, the District of Columbia and Quebec, and $93.5 million will support 29 clinical research data networks that together form PCORnet, the National Patient-Centered Clinical Research Network. Sixteen of the CER projects will focus on health disparities ($37.8 million); 12 will assess prevention, diagnosis and treatment options ($22.4 million); 11 aim to accelerate outcomes and methodological research ($10.1 million); nine will focus on improving health care systems ($17.6 million); and five will research communication and dissemination approaches, including a project at the Baylor College of Medicine in Texas to develop and test a decision aid for ventricular assist device placement.

Since it began funding comparative effectiveness research in 2012, PCORI has awarded $464.4 million to a total of 279 projects,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

Former Top OIG Attorney Gives Inside Look At Fraud Prevention

 
• By 

Former HHS-OIG attorney Rob DeConti emphasized the significance of data analytics and compliance in combating healthcare fraud, urging medical tech companies to adopt robust measures to prevent potential risks.

Deaths And Serious Injuries Linked To A Pair Of Heart Device Recalls

 

Two recent recalls from the US FDA involve three deaths linked to an issue with an Abiomed heart pump — as well as three serious injuries related to angiographic catheters from Cook Medical.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By 

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

June 2025: A Bumper Month For New EU Medtech Documents And Initiatives

 

The rate at which new documents to support the implementation of EU medtech regulations are issued has slowed of late; but June bucked the trend, with a flurry of activity.

More from Medtech Insight

NICE’s Rules-Based Pathway And Innovator Passports Get Go-Ahead In UK NHS 10-Year Plan

 
• By 

The NHS 10-Year Plan officially released on July 3 will crystalize NICE’s Rules-Based Pathway – a new concept for medtech evaluation that will come with a guarantee of funding – but only for a select number of products. Government to also introduce “innovator passport” to speed innovation into NHS.

New Draft Guidance Clarifies FDA’s UDI Rules For Combination Products

 
• By 

The FDA has released draft guidance clarifying UDI rules for drug- and device-led combination products. The document specifies labeling requirements and makes recommendations to reduce confusion between UDIs and NDCs. Comments are being accepted until Sept. 24.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.